1. Repository of OAI
Ελληνικά   English  

Browsing by Author Kosmidis, P.

Jump to: 0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
Jump to: Α Β Γ Δ Ε Ζ Η Θ Ι Κ Λ Μ Ν Ξ Ο Π Ρ Σ Τ Υ Φ Χ Ψ Ω
or enter first few letters:  
View Option
Showing results 21 to 40 of 75 < previous   next >
TitleAuthor(s)Issue date???itemlist.???
Evaluation of 6 Tumor-Markers in Patients with Carcinoma of Unknown PrimaryPavlidis, N.; Kalefezra, J.; Briassoulis, E.; Skarlos, D.; Kosmidis, P.; Saferiadis, K.; Bairaktari, E.; Bafaloukos, D.; Maravegias, A.; Theoharis, D.; Fountzilas, G.24-Nov-2015-
Evaluation of six tumor markers in patients with carcinoma of unknown primaryPavlidis, N.; Kalef-Ezra, J.; Briassoulis, E.; Skarlos, D.; Kosmidis, P.; Saferiadis, K.; Bairaktari, E.; Bafaloukos, D.; Maravegias, A.; Theoharis, D.; et al.,24-Nov-2015-
First line combination chemotherapy with docetaxel and vinorelbine in advanced breast cancer. A phase II studyPectasides, D.; Dimopoulos, M. A.; Aravantinos, G.; Kalophonos, H. P.; Papacostas, P.; Briasoulis, E.; Cogas, E.; Papadimitriou, C.; Skarlos, D.; Kosmidis, P.; Fountzilas, G.24-Nov-2015-
First-line chemotherapy with paclitaxel by three-hour infusion and carboplatin in advanced breast cancer (final report): a phase II study conducted by the Hellenic Cooperative Oncology GroupFountzilas, G.; Dimopoulos, A. M.; Papadimitriou, C.; Kalogera-Fountzila, A.; Aravantinos, G.; Bafaloukos, D.; Athanassiades, A.; Nicolaides, C.; Keramopoulos, A.; Pavlidis, N.; Kosmidis, P.; Skarlos, D.24-Nov-2015-
Fluorouracil and leucovorin with or without interferon alfa-2a as adjuvant treatment, in patients with high-risk colon cancer: a randomized phase III study conducted by the Hellenic Cooperative Oncology GroupFountzilas, G.; Zisiadis, A.; Dafni, U.; Konstantaras, C.; Hatzitheoharis, G.; Papavramidis, S.; Bousoulegas, A.; Basdanis, G.; Giannoulis, E.; Dokmetzioglou, J.; Katsohis, C.; Nenopoulou, E.; Karvounis, N.; Briassoulis, E.; Aravantinos, G.; Kosmidis, P.; Skarlos, D.; Pavlidis, N.24-Nov-2015-
Gemcitabine and vinorelbine as second-line treatment in patients with metastatic breast cancer progressing after first-line taxane-based chemotherapy: a phase II study conducted by the Hellenic Cooperative Oncology GroupNicolaides, C.; Dimopoulos, M. A.; Samantas, E.; Bafaloukos, D.; Kalofonos, C.; Fountzilas, G.; Razi, E.; Kosmidis, P.; Pavlidis, N.24-Nov-2015-
Gemcitabine plus pegylated liposomal doxorubicin in patients with advanced epithelial ovarian cancer resistant/refractory to platinum and/or taxanes. A HeCOG phase II studySkarlos, D. V.; Kalofonos, H. P.; Fountzilas, G.; Dimopoulos, M. A.; Pavlidis, N.; Razis, E.; Economopoulos, T.; Pectasides, D.; Gogas, H.; Kosmidis, P.; Bafaloukos, D.; Klouvas, G.; Kyratzis, G.; Aravantinos, G.24-Nov-2015-
High-dose epirubicin and r-met-hu G-CSF (filgrastim) in the treatment of patients with advanced breast cancer: A Hellenic Cooperative Oncology Group studyFountzilas, G.; Skarlos, D.; Katsohis, C.; Pavlidis, N.; Giannakakis, T.; Bafaloukos, D.; Fahantidis, E.; Klouvas, G.; Beer, M.; Kosmidis, P.24-Nov-2015-
High-dose epirubicin as a single agent in the treatment of patients with advanced breast cancer. A Hellenic Co-operative Oncology Group studyFountzilas, G.; Skarlos, D.; Pavlidis, N. A.; Makrantonakis, P.; Tsavaris, N.; Kalogera-Fountzila, A.; Giannakakis, T.; Beer, M.; Kosmidis, P.24-Nov-2015-
Ifosfamide plus oral etoposide salvage chemotherapy for platinum-resistant paclitaxel-pretreated ovarian cancerAravantinos, G.; Dimopoulos, M. A.; Kosmidis, P.; Bafaloukos, D.; Papadimitriou, C.; Kiamouris, C.; Pavlidis, N.; Sikiotis, K.; Papakostas, P.; Skarlos, D. V.24-Nov-2015-
Induction Chemotherapy with Docetaxel and Cisplatin Followed by Concomitant Chemoradiotherapy in Patients with Inoperable Non-nasopharyngeal Carcinoma of the Head and NeckFountzilas, G.; Bamias, A.; Kalogera-Fountzila, A.; Karayannopoulou, G.; Bobos, M.; Athanassiou, E.; Kalogeras, K. T.; Tolis, C.; Tsekeris, P.; Papakostas, P.; Vamvouka, C.; Zaramboukas, T.; Kosmidis, P.; Zamboglou, N.; Misailidou, D.24-Nov-2015-
Inherited cancer predisposition syndromes in GreeceApessos, A.; Papadopoulou, E.; Belogianni, I.; Baratsis, S.; Triantafillidis, J. K.; Kosmidis, P.; Karydas, E.; Briasoulis, E.; Pisiotis, C.; Papazisis, K.; Nasioulas, G.24-Nov-2015-
Intensified carboplatin regimen with GM-CSF support in non-small cell lung cancer (NSCLC). A Hellenic Co-operative Oncology Group Study (HeCOG)Nicolaides, C.; Klouvas, G.; Fountzilas, G.; Athanassiadis, A.; Skarlos, D.; Samantas, E.; Kosmidis, P.; Mylonakis, N.; Pavlidis, N.24-Nov-2015-
Intensive chemotherapy with high-dose epirubicin every 2 weeks and prophylactic administration of filgrastim in advanced breast cancerFountzilas, G.; Skarlos, D.; Giannakakis, T.; Athanasiadis, A.; Bafaloukos, D.; Kalogera-Fountzila, A.; Bamia, C.; Pavlidis, N.; Kosmidis, P.24-Nov-2015-
Irinotecan/fluorouracil/leucovorin or the same regimen followed by oxaliplatin/fluorouracil/leucovorin in metastatic colorectal cancerKalofonos, H. P.; Papakostas, P.; Makatsoris, T.; Papamichael, D.; Vourli, G.; Xanthakis, I.; Aravantinos, G.; Papadimitriou, C.; Pentheroudakis, G.; Varthalitis, I.; Samelis, G.; Syrigos, K. N.; Xiros, N.; Stavropoulos, M.; Kosmidis, P.; Christodoulou, C.; Linardou, H.; Skondra, M.; Pectasides, D.; Economopoulos, T.; Fountzilas, G.24-Nov-2015-
Mechanisms of resistance to epidermal growth factor receptor tyrosine kinase inhibitors in patients with advanced non-small-cell lung cancer: clinical and molecular considerationsPallis, A.; Briasoulis, E.; Linardou, H.; Papadimitriou, C.; Bafaloukos, D.; Kosmidis, P.; Murray, S.24-Nov-2015-
Megestrol acetate in cancer patients with anorexia and weight loss. A Hellenic Co-operative Oncology Group (HeCOG) studySkarlos, D. V.; Fountzilas, G.; Pavlidis, N.; Beer, M.; Makrantonakis, P.; Aravantinos, G.; Pantelakos, P.; Tsavaris, N.; Karpasitis, N.; Kosmidis, P.24-Nov-2015-
Myelotoxicity as a prognostic factor in patients with advanced breast cancer treated with chemotherapy: a pooled analysis of two randomised trials conducted by the Hellenic Cooperative Oncology GroupKoutras, A. K.; Fountzilas, G.; Dafni, U.; Dimopoulos, M. A.; Pectasides, D.; Klouvas, G.; Papakostas, P.; Kosmidis, P.; Samantas, E.; Gogas, H.; Briasoulis, E.; Vourli, G.; Petsas, T.; Xiros, N.; Kalofonos, H. P.24-Nov-2015-
Non small cell lung cancer in the elderly: clinico-pathologic, management and outcome characteristics in comparison to younger patientsKoumarianou, A.; Fountzilas, G.; Kosmidis, P.; Klouvas, G.; Samantas, E.; Kalofonos, C.; Pentheroudakis, G.; Economopoulos, T.; Pectasides, D.24-Nov-2015-
Non-small cell lung cancer in the young: a retrospective analysis of diagnosis, management and outcome dataMauri, D.; Pentheroudakis, G.; Bafaloukos, D.; Pectasides, D.; Samantas, E.; Efstathiou, E.; Kalofonos, H. P.; Syrigos, K.; Klouvas, G.; Papakostas, P.; Kosmidis, P.; Fountzilas, G.; Pavlidis, N.24-Nov-2015-
Showing results 21 to 40 of 75 < previous   next >